Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant

Masayuki Hayashi1, Taiki Aoshi2, Yasumichi Kogai3

  • 1Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka 567-0085, Japan; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (iFReC), Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan; Vaccine Research Development Office, Biology Research Laboratories, Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Kanagawa, Japan.

Vaccine
|December 16, 2015
PubMed

Related Concept Videos